DLL4 targeting miRNA program (University college London)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameDLL4 targeting miRNA program (University college London)
Drug Alias Nameanti-angiogenesis miRNA therapy (University College London)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionDelta-like protein 4 inhibitorsAngiogenin inhibitors
TargetsAngiogeninDelta-like protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUCL Business PLCUniversity College London
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A